- Home
- AFG vs BMRN Comparison
AFG vs BMRN Comparison
Compare AFG & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AFG
- BMRN
- Stock Information
- Founded
- AFG 1872
- BMRN 1996
- Country
- AFG United States
- BMRN United States
- Employees
- AFG N/A
- BMRN N/A
- Industry
- AFG Property-Casualty Insurers
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- AFG Finance
- BMRN Health Care
- Exchange
- AFG Nasdaq
- BMRN Nasdaq
- Market Cap
- AFG 11.3B
- BMRN 10.0B
- IPO Year
- AFG N/A
- BMRN 1999
- Fundamental
- Price
- AFG $142.51
- BMRN $51.52
- Analyst Decision
- AFG Hold
- BMRN Buy
- Analyst Count
- AFG 4
- BMRN 19
- Target Price
- AFG $134.00
- BMRN $90.26
- AVG Volume (30 Days)
- AFG 444.5K
- BMRN 2.9M
- Earning Date
- AFG 11-04-2025
- BMRN 10-27-2025
- Dividend Yield
- AFG 2.46%
- BMRN N/A
- EPS Growth
- AFG N/A
- BMRN 59.53
- EPS
- AFG 9.52
- BMRN 2.68
- Revenue
- AFG $8,011,000,000.00
- BMRN $3,094,001,000.00
- Revenue This Year
- AFG N/A
- BMRN $13.32
- Revenue Next Year
- AFG $7.22
- BMRN $7.51
- P/E Ratio
- AFG $15.02
- BMRN $19.20
- Revenue Growth
- AFG 1.20
- BMRN 12.39
- 52 Week Low
- AFG $114.73
- BMRN $50.76
- 52 Week High
- AFG $150.19
- BMRN $73.51
- Technical
- Relative Strength Index (RSI)
- AFG 64.42
- BMRN 40.53
- Support Level
- AFG $128.72
- BMRN $51.80
- Resistance Level
- AFG $132.05
- BMRN $53.49
- Average True Range (ATR)
- AFG 3.03
- BMRN 1.84
- MACD
- AFG 1.14
- BMRN -0.08
- Stochastic Oscillator
- AFG 95.50
- BMRN 12.58
About AFG American Financial Group Inc.
American Financial Group Inc is a holding company that is engaged in property and casualty insurance services. The company has a focus on specialized commercial products for businesses. The Company operates through two segments: Property & Casualty Insurance and Other. The Property & Casualty segment includes Property & Transportation, covering buses, trucks, marine, agriculture, and commercial property; Specialty Casualty, offering excess & surplus, liability, and professional insurance; and Specialty Financial, providing risk management for lending and leasing institutions, fidelity and surety products, and trade credit insurance. The company's insurance operations are conducted through the Great American Insurance Group.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.